Burkitt lymphoma in South African children: one or two entities?

D Cristina Stefan1, D Stones, R Newton

  • 1Department of Paediatrics and Child Health, Tygerberg Hospital and Stellenbosch University, Tygerberg, Cape Town, South Africa. cs@sun.ac.za

Insights

HIV infection significantly worsens outcomes for children with Burkitt's lymphoma (BL). Survival rates are markedly lower in HIV-positive pediatric BL patients compared to HIV-negative ones, despite treatment.

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • Hematology

Background:

  • Limited research exists on Burkitt's lymphoma (BL) in HIV-infected children.
  • Understanding clinical presentation and treatment outcomes in this population is crucial.

Purpose of the Study:

  • To compare the clinical presentation and outcomes of HIV-infected children with BL to those without HIV infection.
  • To identify factors influencing prognosis in pediatric BL.

Main Methods:

  • Retrospective analysis of 15 HIV-infected and 30 HIV-negative pediatric BL patients.
  • Data collected from two South African hospitals (1995-2004).
  • Compared tumor site, stage, treatment, relapse, and survival rates.

Main Results:

  • No significant differences in age, sex, or disease stage between groups.
  • Abdominal tumors were more common in HIV-negative (80%) than HIV-positive (53%) cases.
  • Mortality was significantly higher in HIV-positive children (73%) versus HIV-negative (23%).

Conclusions:

  • HIV infection substantially worsens the prognosis for children diagnosed with Burkitt's lymphoma.
  • Despite anti-retroviral and cytostatic therapies, HIV-positive pediatric BL patients face poorer outcomes.
Abstract